Psychiatry & Mental Health Clinical Trials

Statistical methods in psychiatry & mental health trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All psychiatry & mental health trials

521 results

• 1/2 A Multi-site Systems Intervention for Unemployed Persons With Social Anxiety: Complete Statistical AnalysisIndependent statistical analysis of 1/2 A Multi-site Systems Intervention for Unemployed Persons With Social Anxiety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 250NCT02633267
• 12 Month Open Extension of TNS for ADHD.: Complete Statistical AnalysisIndependent statistical analysis of 12 Month Open Extension of TNS for ADHD.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03888391).Phase NAResults postedn = 18NCT03888391
• 12- Week Open Label Treatment of Refractory Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of 12- Week Open Label Treatment of Refractory Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00223496).Phase 4Results postedn = 32NCT00223496
• 18F-AV-1451 Autopsy Study: Complete Statistical AnalysisIndependent statistical analysis of 18F-AV-1451 Autopsy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02516046).Phase 3Results postedn = 156NCT02516046
• 2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD: Complete Statistical AnalysisIndependent statistical analysis of 2/2 D-Cycloserine Augmentation of CBT for Pediatric OCD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01404208).Phase NAResults postedn = 206NCT01404208
• 2CAREIndependent statistical analysis of Coenzyme Q10 in Huntington's Disease (HD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00608881).Phase 3Results postedn = 609NCT00608881
• A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation: Complete Statistical AnalysisIndependent statistical analysis of A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation: primary endpoint results,…Phase 3Results postedn = 302NCT01395524
• A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features: Complete Statistical AnalysisIndependent statistical analysis of A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features: primary endpoint results,…Phase 3Results postedn = 901NCT03573297
• A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) Imaging: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET)…Phase 1Results postedn = 22NCT04038957
• A Digital Intervention to Prevent the Initiation of Opioid Misuse in Adolescents in School-based Health Centers: Complete Statistical AnalysisIndependent statistical analysis of A Digital Intervention to Prevent the Initiation of Opioid Misuse in Adolescents in School-based Health Centers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 533NCT04941950
• A Double Blind Clinical Trial of DCS for Food Anxiety: Complete Statistical AnalysisIndependent statistical analysis of A Double Blind Clinical Trial of DCS for Food Anxiety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01996644).Phase NAResults postedn = 47NCT01996644
• A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 4Results postedn = 249NCT00960986
• A Folinic Acid Intervention for Autism Spectrum Disorders: Complete Statistical AnalysisIndependent statistical analysis of A Folinic Acid Intervention for Autism Spectrum Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01602016).Phase 2Results postedn = 99NCT01602016
• A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer’s Disease (TRAILBLAZER-EXT): Complete Statistical AnalysisIndependent statistical analysis of A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 95NCT04640077
• A Home-based Training Program for Elderly Patients With Dementia: Complete Statistical AnalysisIndependent statistical analysis of A Home-based Training Program for Elderly Patients With Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02667951).Phase NAResults postedn = 129NCT02667951
• A Long-term Trial of OPC-34712 in Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Long-term Trial of OPC-34712 in Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01456897).Phase 3Results postedn = 282NCT01456897
• A Mobile Executive Functioning Intervention for Momentary Craving in Opioid Use Disorders: Complete Statistical AnalysisIndependent statistical analysis of A Mobile Executive Functioning Intervention for Momentary Craving in Opioid Use Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 10NCT05086835
• A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2): Complete Statistical AnalysisIndependent statistical analysis of A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 121NCT04077437
• A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode: Complete Statistical AnalysisIndependent statistical analysis of A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing…Phase 3Results postedn = 41NCT00606229
• A Multidomain Intervention Program for Older People With Dementia: Complete Statistical AnalysisIndependent statistical analysis of A Multidomain Intervention Program for Older People With Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04948450).Phase NAResults postedn = 60NCT04948450
• A Patient-facing Tool to Reduce Opioid-Psychotropic Polypharmacy in People Living With Dementia (PLWD): Complete Statistical AnalysisIndependent statistical analysis of A Patient-facing Tool to Reduce Opioid-Psychotropic Polypharmacy in People Living With Dementia (PLWD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 129NCT05628181
• A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 26NCT03900754
• A Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers: Complete Statistical AnalysisIndependent statistical analysis of A Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03303911).Phase 1/2Results postedn = 26NCT03303911
• A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers: Complete Statistical AnalysisIndependent statistical analysis of A Pharmacokinetic Evaluation of Two Nicotine Patches in Smokers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01702519).Phase 1Results postedn = 40NCT01702519
• A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01626859).Phase 2/3Results postedn = 38NCT01626859
• A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A Phase 4 Study to Assess the Effects of Aripiprazole Versus Other Atypical Antipsychotics in the Treatment of Schizophrenic Patients With Metabolic Syndrome: primary endpoint results, effect estimate…Phase 4Results postedn = 125NCT00508157
• A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150): Complete Statistical AnalysisIndependent statistical analysis of A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 3Results postedn = 369NCT00770692
• A Pilot Feasibility Study of Mindfulness-Oriented Recovery Enhancement With Pregnant Women With Opioid Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Feasibility Study of Mindfulness-Oriented Recovery Enhancement With Pregnant Women With Opioid Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 1NCT04824521
• A Pilot Study Assessing EmSam in Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study Assessing EmSam in Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00535262).Phase 4Results postedn = 3NCT00535262
• A Pilot Study of Daytrana TM in Children With Autism Co-Morbid for Attention Deficit Hyperactivity Disorder (ADHD) Symptoms: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study of Daytrana TM in Children With Autism Co-Morbid for Attention Deficit Hyperactivity Disorder (ADHD) Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 16NCT00541346
• A Pilot Study of Suvorexant for Insomnia in Parkinson Disease: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study of Suvorexant for Insomnia in Parkinson Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02729714).Phase 4Results postedn = 21NCT02729714
• A Prenatal Bonding Intervention for Pregnant Women With Depression: Complete Statistical AnalysisIndependent statistical analysis of A Prenatal Bonding Intervention for Pregnant Women With Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05628675).Phase NAResults postedn = 21NCT05628675
• A Proof-of-concept RCT of Version 3.0 of the Smoking Cessation Smartphone App “Smiling Instead of Smoking” (SiS): Complete Statistical AnalysisIndependent statistical analysis of A Proof-of-concept RCT of Version 3.0 of the Smoking Cessation Smartphone App "Smiling Instead of Smoking" (SiS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase NAResults postedn = 229NCT04672239
• A Prospective Study Investigating the Use of Relaxation Prior to Medical Procedures.: Complete Statistical AnalysisIndependent statistical analysis of A Prospective Study Investigating the Use of Relaxation Prior to Medical Procedures.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 54NCT02690194
• A Randomized Controlled Trial of In-Home Tele-Behavioral Health Care Utilizing Behavioral Activation for Depression: Complete Statistical AnalysisIndependent statistical analysis of A Randomized Controlled Trial of In-Home Tele-Behavioral Health Care Utilizing Behavioral Activation for Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 121NCT01599585
• A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD: Complete Statistical AnalysisIndependent statistical analysis of A Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety and Efficacy of PCN-101 in TRD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 102NCT05414422
• A Response Modulation Hypothesis of Socioemotional Processing Associated With Alcohol Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Response Modulation Hypothesis of Socioemotional Processing Associated With Alcohol Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 101NCT03535129
• A Sensor-enhanced Mouth Guard to Quantitatively Measure Bite Compression Forces.: Complete Statistical AnalysisIndependent statistical analysis of A Sensor-enhanced Mouth Guard to Quantitatively Measure Bite Compression Forces.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06688474).Phase NAResults postedn = 2NCT06688474
• A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults: Complete Statistical AnalysisIndependent statistical analysis of A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 61NCT05897242
• A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression: Complete Statistical AnalysisIndependent statistical analysis of A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00422162).Phase 4Results postedn = 339NCT00422162
• A Study of a Mobile Phone Application Measuring the Eyes Before and After Medication: Complete Statistical AnalysisIndependent statistical analysis of A Study of a Mobile Phone Application Measuring the Eyes Before and After Medication: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 34NCT06629740
• A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder: Complete Statistical AnalysisIndependent statistical analysis of A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 300NCT02161718
• A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 4Results postedn = 51NCT02634320
• A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn: Complete Statistical AnalysisIndependent statistical analysis of A Study of Dexlansoprazole Modified Release Formulation to Treat Night Heartburn: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 305NCT00627016
• A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase: Complete Statistical AnalysisIndependent statistical analysis of A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 3Results postedn = 142NCT01278407
• A Study of L-DOPA for Depression and Slowing in Older Adults: Complete Statistical AnalysisIndependent statistical analysis of A Study of L-DOPA for Depression and Slowing in Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 4Results postedn = 47NCT02744391
• A Study of Loco-Regional Liposomal Bupivacaine Injection: Complete Statistical AnalysisIndependent statistical analysis of A Study of Loco-Regional Liposomal Bupivacaine Injection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05992896).Phase 4Results postedn = 3NCT05992896
• A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 2Results postedn = 167NCT01052103
• A Study of LY2624803 in Japanese Participants With Transient Insomnia: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY2624803 in Japanese Participants With Transient Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01784614).Phase 1Results postedn = 24NCT01784614
• A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 2Results postedn = 327NCT05063539

← All therapeutic areas